Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. Pharmacol Rev. 2023

Maccarrone M, Di Marzo V, Gertsch J, Grether U, Howlett AC, Hua T, Makriyannis A, Piomelli D, Ueda N, van der Stelt M. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. Pharmacol Rev. 2023 Sep;75(5):885-958. doi: 10.1124/pharmrev.122.000600. Epub 2023 May 10. Erratum in: Pharmacol Rev. 2023 Dec 15;76(1):194. doi: 10.1124/pharmrev.122.000600err. PMID: 37164640; PMCID: PMC10441647.

https://pharmrev.aspetjournals.org/content/75/5/885